Variables

Patient no. (%)

Group I^a (N = 522)

Group II^b (N = 191)

P value

Low doses

363 (69.5)

15 (7.9)

<0.0001

Standard doses

154 (29.5)

175 (91.6)

<0.0001

High doses

5 (1.0)

1 (0.5)

Rifampicin-resistance

238 (45.6)

72 (37.7)

0.0304

Successful treatment outcomes

243 (46.6)

105 (55.0)

0.0093